Hong Kong, U.S. Scientists Find Quick, Cheap Way To Produce Vaccines
This article was originally published in PharmAsia News
Executive SummaryScientists in Hong Kong and the United States jointly report development of a more effective and less costly way to produce vaccines, possibly a way to avoid pandemics. The researchers, which included a team from the University of Hong Kong, said their vaccine is a modified version of the smallpox vaccine, and is expected to undergo human trials in about two years. The scientists also plan to use their strategy to create a universal influenza vaccine to cover a wide range of viruses and various strains, including the H5N1 avian flu virus. (Click here for more
You may also be interested in...
Dr Reddy’s Laboratories reported an unexpected third-quarter consolidated net loss after taking a $156m charge related to its generic version of the NuvaRing contraceptive. However, the company’s shares jumped on a robust underlying performance that was praised by analysts.
Royal Philips is planning to sell its domestic appliance business to better focus on its strategic aims in health technology. The group made the announcement as it unveiled 2019 sales up 4.5% on a comparable basis.
With just under 120 days until the full application of the EU’s Medical Device Regulation, and fears growing of the loss of products seen as non-compliant, the EU medtech industry has identified a way of broadening the application of the “grace period.” It is a legal way of addressing the potential loss of tens of thousands of products come 26 May, says MedTech Europe’s Oliver Bisazza.